Alerts will be sent to your verified email
Verify Email
LYKALABS
|
Lyka Labs
|
Zim Laboratories
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
62.44 % | 7.41 % | 35.94 % |
|
5yr average Equity Multiplier
|
2.9 | 1.88 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
0.73 | 0.94 | 0.9 |
|
5yr Avg Net Profit Margin
|
-0.79 % | 4.15 % | 17.11 % |
|
Price to Book
|
3.45 | 1.46 | 5.84 |
|
P/E
|
47.57 | 39.26 | 28.62 |
|
5yr Avg Cash Conversion Cycle
|
32.55 Days | 37.07 Days | 94.4 Days |
|
Inventory Days
|
24.2 Days | 68.72 Days | 68.55 Days |
|
Days Receivable
|
92.33 Days | 99.71 Days | 104.41 Days |
|
Days Payable
|
106.74 Days | 143.26 Days | 126.58 Days |
|
5yr Average Interest Coverage Ratio
|
2.2 | 3.96 | 17.94 |
|
5yr Avg ROCE
|
25.83 % | 13.52 % | 29.15 % |
|
5yr Avg Operating Profit Margin
|
24.02 % | 12.21 % | 16.89 % |
|
5 yr average Debt to Equity
|
1.25 | 0.39 | 0.34 |
|
5yr CAGR Net Profit
|
n/a | 10.7 % | 9.93 % |
|
5yr Average Return on Assets
|
1.72 % | 4.02 % | 15.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
58.16 % | 33.26 % | 63.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.46 % |
|
Change in Promoter Holding (3 Yrs)
|
10.36 % | 0.0 | -6.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-3.53 % | 0.0 | 0.0 |
|
Lyka Labs
|
Zim Laboratories
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|